LONDON (ShareCast) - (ShareCast News) - Specialist pharmaceutical company N4 Pharma welcomed the government's announcement this week to make Viagra available as an over the counter product in the UK and said it was working on bringing its own faster-acting and longer-lasting version to market.
The N4 Pharma said it would work on granting the prescription medicine used in the treatment of erectile dysfunction and impotence in men, over the counter status.

Nigel Theobald, CEO of N4 Pharma, commented: "Unlike in the USA, prescription products cannot be advertised directly to consumers in Europe and this move to OTC will make that possible in the UK for sildenafil.

"The establishment of an OTC market for sildenafil in the UK will bring many opportunities for reformulated products as has happened in other OTC sectors. If this OTC status is widely supported by pharmacists in the UK, our 50mg reformulation of sildenafil will also be able to apply for OTC status."

Last month N4 applied for a patent for a proposed reformulation for a drug that would be faster acting and longer lasting version of Viagra, for which it will begin looking for human testers in the coming months.

Theoblad said the OTC news was a good endorsement of its decision to reformulate sildenafil.

The company focuses on reformulating existing drugs and vaccines enhancing their performance.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE